|
1
|
Campbell D and Weir MR: Defining, treating
and understanding chronic kidney disease-A complex disorder. J Clin
Hypertens (Greenwich). 17:514–527. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Granata G, Greco A, Iannella G, Granata M,
Manno A, Savastano E and Magliulo G: Posterior reversible
encephalopathy syndrome-Insight into pathogenesis, clinical
variants and treatment approaches. Autoimmun Rev. 14:830–836. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pula JH and Eggenberger E: Posterior
reversible encephalopathy syndrome. Curr Opin Ophthalmol.
19:479–484. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ollivier M, Bertrand A, Clarençon F,
Gerber S, Deltour S, Domont F, Trunet S, Dormont D and Leclercq D:
Neuroimaging features in posterior reversible encephalopathy
syndrome: A pictorial review. J Neurol Sci. 373:188–200. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartynski WS: Posterior reversible
encephalopathy syndrome, part 2: Controversies surrounding
pathophysiology of vasogenic edema. AJNR Am J Neuroradiol.
29:1043–1049. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hinchey J, Chaves C, Appignani B, Breen J,
Pao L, Wang A, Pessin MS, Lamy C, Mas JL and Caplan LR: A
reversible posterior leukoencephalopathy syndrome. N Engl J Med.
334:494–500. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nakabou M, Kai T, Maeshima T and Kanamasa
K: Hypertensive encephalopathy in patients with chronic renal
failure caused by stopping antihypertensive agents: A report of two
cases. Clin Exp Nephrol. 14:256–262. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang HL, Yang Y and Wu J: Posterior
reversible encephalopathy syndrome in ANCA-associated vasculitis.
Rheumatol Int. 32:1847–1848. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fujieda Y, Kataoka H, Odani T, Otomo K,
Kato M, Fukaya S, Oku K, Horita T, Yasuda S, Atsumi T and Koike T:
Clinical features of reversible posterior leukoencephalopathy
syndrome in patients with systemic lupus erythematosus. Mod
Rheumatol. 21:276–281. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Burrus TM, Mandrekar J, Wijdicks EF and
Rabinstein AA: Renal failure and posterior reversible
encephalopathy syndrome in patients with thrombotic
thrombocytopenic purpura. Arch Neurol. 67:831–834. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liman TG, Bohner G, Heuschmann PU, Endres
M and Siebert E: The clinical and radiological spectrum of
posterior reversible encephalopathy syndrome: The retrospective
Berlin PRES study. J Neurol. 259:155–164. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kidney Disease: Improving Global Outcomes
(KDIGO) CKD work group: KDIGO 2012 clinical practice guideline for
the evaluation and management of chronic kidney disease. Kidney Int
Suppl. 3:1–150. 2013.
|
|
13
|
Gao B, Liu FL and Zhao B: Association of
degree and type of edema in posterior reversible encephalopathy
syndrome with serum lactate dehydrogenase level: Initial
experience. Eur J Radiol. 81:2844–2847. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yamada A and Ueda N: Age and gender may
affect posterior reversible encephalopathy syndrome in renal
disease. Pediatr Nephrol. 27:277–283. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fuentes AG, Komarla A and Gomez JI:
Posterior reversible encephalopathy syndrome in a patient with
ANCA-associated vasculitis. Rheumatol Int. 32:2529–2530. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin CY, Chen HC, Hwang WL and Teng CL:
Immune thrombocytopenic pupura-induced reversible posterior
leukoencephalopathy successfully treated by rituximab. Ann Hematol.
90:731–732. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Piccin A, Dossi RC, Cassibba V, Stupnner
S, Bonatti G and Cortelazzo S: Anti-thrombin-III reduction and
posterior reversible encephalopathy syndrome (PRES) in acute
lymphoblastic leukaemia (ALL). New insight into PRES
pathophysiology. Ann Hematol. 91:1153–1155. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hadj JO, Braven RD, Tillier C, Schrijver
HM, Verheul HM and VAN DER Vliet HJ: Reversible posterior
leukoencephalopathy syndrome during sunitinib therapy for
metastatic renal cell carcinoma. Oncol Lett. 3:1293–1296.
2012.PubMed/NCBI
|
|
19
|
Nasu K, Fujisawa M, Kato H and Nangaku M:
Three cases of posterior reversible encephalopathy syndrome with
chronic kidney disease triggered by infection. Nephrology
(Carlton). 22:322–325. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Canney M, Kelly D and Clarkson M:
Posterior reversible encephalopathy syndrome in end-stage kidney
disease: Not strictly posterior or reversible. Am J Nephrol.
41:177–182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vargas M, Servillo G and Striano P: Serum
lactate dehydrogenase as early marker of posterior reversible
encephalopathy syndrome: Keep your eyes open. Anaesth Intensive
Care. 40:570–571. 2012.PubMed/NCBI
|
|
22
|
Pawlak K, Naumnik B, Brzósko S, Pawlak D
and Myśliwiec M: Oxidative stress-a link between endothelial
injury, coagulation activation, and atherosclerosis in
haemodialysis patients. Am J Nephrol. 24:154–161. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stenvinkel P: Endothelial dysfunction and
inflammation-is there a link? Nephrol Dial Transplant.
16:1968–1971. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tepperman E, Ramzy D, Prodger J, Sheshgiri
R, Badiwala M, Ross H and Raoa V: Surgical biology for the
clinician: Vascular effects of immunosuppression. Can J Surg.
53:57–63. 2010.PubMed/NCBI
|
|
25
|
Yoon HE and Yang CW: Established and newly
proposed mechanisms of chronic cyclosporine nephropathy. Korean J
Intern Med. 24:81–92. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huynh TN, Chacko BK, Teng X, Brott BC,
Allon M, Kelpke SS, Thompson JA, Patel RP and Anayiotos AS: Effects
of venous needle turbulence during ex vivo hemodialysis on
endothelial morphology and nitric oxide formation. J Biomech.
40:2158–2166. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lilien MR, Koomans HA and Schröder CH:
Hemodialysis acutely impairs endothelial function in children.
Pediatr Nephrol. 20:200–204. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li R, Mitchell P, Dowling R and Yan B: Is
hypertension predictive of clinical recurrence in posterior
reversible encephalopathy syndrome? J Clin Neurosci. 20:248–252.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Siddall EC and Radhakrishnan J: The
pathophysiology of edema formation in the nephrotic syndrome.
Kidney Int. 82:635–642. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mackow ER, Gorbunova EE and Gavrilovskaya
IN: Endothelial cell dysfunction in viral hemorrhage and edema.
Front Microbiol. 5:7332015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Asikainen TM, Ahmad A, Schneider BK, Ho
WB, Arend M, Brenner M, Günzler V and White CW: Stimulation of
HIF-1alpha, HIF-2alpha and VEGF by prolyl 4-hydroxylase inhibition
in human lung endothelial and epithelial cells. Free Radic Biol
Med. 38:1002–1013. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Delanty N, Vaughan C, Frucht S and Stubgen
P: Erythropoietin-associated hypertensive posterior
leukoencephalopathy. Neurology. 49:686–689. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Miller YI, Altamentova SM and Shaklai N:
Oxidation of low-density lipoprotein by hemoglobin stems from a
heme-initiated globin radical: Antioxidant role of haptoglobin.
Biochemistry. 36:12189–12198. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Belcher JD, Beckman JD, Balla G, Balla J
and Vercellotti G: Heme degradation and vascular injury. Antioxid
Redox Signal. 12:233–248. 2010. View Article : Google Scholar : PubMed/NCBI
|
